Clinical Trial

A Response Surface Analysis for the Interaction Between Ciprofol and Sevoflurane

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Intravenous and inhalation combined anesthesia is a commonly used method for maintaining general anesthesia in clinical practice. This study aims to explore the interaction between ciprofol and sevoflurane. By employing response surface methodology, we constructed a three-dimensional pharmacodynamic interaction surface for various dose combinations of ciprofol and sevoflurane. This approach allows us to determine the nature of the interaction between the two drugs at any given level, thereby providing a ciprofol understanding of the dose-response relationship when ciprofol and sevoflurane are used in combination. This knowledge will serve as a theoretical basis for rational drug administration during surgery.
Trial Details
NCT Number NCT06773351
Lead Sponsor Feng Gao
Collaborators: Sichuan Provincial People's Hospital
Conditions Induction of General Anesthesia
Enrollment 300 participants
Start Date 2025-02-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-14